Close Menu

NEW YORK — GenomeSmart said on Tuesday that specialty medical technology firm Aspira Labs will evaluate its GenomeBrain digital genetic test recommendation platform under a pilot program.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.